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A comparative study of lactogen receptors in lactogenic hormone-dependent (Nb2-1lC) and independent 
(Nb2-SP) rat lymphoma cell lines revealed no significant differences in their binding and structural charac- 
teristics. The affinity for human growth hormone (hGH) and ovine prolactin is identical (& = 1.3 x lo-lo M). 
Exposure to hGH results in a rapid receptor down-regulation. This process is faster in Nb2-SP cells, howev- 
er, similar receptor levels are reached within 3 h. Affinity labeling revealed 2 major binding species (Mr 75 000 
and 29 000) in both cell lines. These observations uggest hat the spontaneous proliferation of NbZSP cells 
probably results from an aberration in some post-receptoral event of the mitogenic pathway. 
(Nb2 lymphoma cell); Prolactin; Human growth hormone; Lactogen receptor 
1. INTRODUCTION 
Prolactin (PRL), similar to many polypeptide 
hormones, initiates its biological action by binding 
to its specific receptor on the membranes of target 
cells. Nb2 lymphoma cells, which are absolutely 
dependent on lactogenic hormones for their pro- 
liferation [ 1,2], have proved to be a most suitable 
and sensitive in vitro cell model for studying the 
mechanism of mitogenic action of lactogenic hor- 
mones, such as PRL or human growth hormone 
(hGH) [3-91. Recently, two cell lines derived from 
the original Nb2 strain, one of which is lactogen- 
dependent (Nb2-11C) and another, which is 
lactogen-independent (Nb2-SP), have been 
established [4,6]. These cells can be propagated in 
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continuous suspension cultures in medium sup- 
plemented with either fetal calf serum that con- 
tains lactogenic hormones (Nb2-1 lC), or 
lactogen-free horse serum (Nb2-SP). The 
autonomous proliferation of the NbZSP cell line 
has raised the question of whether the lactogen 
receptors in these cells have a mitogen- 
independent, constitutively activated conforma- 
tion. It has recently been reported [lo] that the 
transforming protein of avian erythroblastosis 
virus (e&-B) is apparently a truncated EGF recep- 
tor, lacking the extracellular EGF-binding domain, 
but not the internal and most of the transmem- 
brane part of the receptor. The lack of the 
regulatory EGF-binding domain may then be ac- 
companied by a constitutive activation of the ef- 
fector domain. Here, we compare the binding and 
structural characteristics of the lactogen receptors 
in the lactogen-dependent and -independent cell 
lines, in order to assess the possibility that the 
receptor itself triggers the mitogenic pathway in 
the spontaneously proliferating cell line. 
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2. MATERIALS AND METHODS 
2.1. Hormones and reagents 
The sources of all the hormones used in this 
research were described in our previous paper [5]. 
Radioiodinated hGH (12?-hGH) was prepared as 
described in [ 111. Carrier-free Na1251 was obtained 
from Amersham (Bucks, England). Fischer’s 
medium for leukemic cells and RPM1 1640 
medium were obtained from Gibco (Grand Island, 
NY). Fetal calf serum (FCS) and lactogen-free 
horse serum (HS) were obtained from Sera-Lab 
(Sussex, England). Reagents for SDS-polyacryl- 
amide gel electrophoresis (SDS-PAGE) were ob- 
tained from Bio-Rad (Richmond, CA). M, 
standards, dithiothreitol (DTT) and bovine y- 
globulin (bgG) from Sigma (St. Louis, MO), and 
disuccinimidyl suberate (DSS) from Pierce 
(Rockford, IL). 
2.2. Nb2 lymphoma cells culture 
Two cloned Nb2 lymphoma cell lines, developed 
in Dr H.G. Friesen’s lab (H. Cosby), were 
employed. Cells were cultured as in [l-4], except 
that stock cultures of Nb2-11C cells were main- 
tained in RPM1 1640 medium, supplemented with 
25 mM Hepes buffer (pH 7.4), instead of Fischer’s 
medium. Synchronization of cells in the Go/G1 
phase and monitoring of cell proliferation were 
carried out as described [4]. 
2.3. Measurement of binding 
The binding of 12’I-hGH was assayed in cell 
homogenates or in intact cells. Homogenates were 
prepared from synchronized cells, which were 
pelleted, resuspended in HS-supplemented Fisch- 
er’s medium (3.2 x lo6 cells/ml) and homogenized 
in an Ultraturrax (3 x 15 s at 120 rpm). 0.5 ml ali- 
quots of the homogenate suspension were trans- 
ferred to Eppendorf tubes and incubated for 16 h 
at 25°C with 1.5 x lo5 cpm 1251-hGH in the 
presence of increasing concentrations (O-7 nM) of 
unlabeled hGH or ovine PRL (oPRL). The reac- 
tion was terminated by addition of 1 vol. of ice- 
cold buffer (25 mM Tris-HCl, 10 mM MgCl2, 
0.2% bgG, pH 7.5) followed by centrifugation 
(5 min, 11000 x g). The supernatant was removed 
and the pellets were counted in a Kontron MR-430 
gamma counter. The binding to intact cells was 
measured with synchronized cells, which were 
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pelleted and resuspended in HS-supplemented 
Fischer’s medium (3 x lo6 cells/ml). 1 ml aliquots 
of the cell suspension were transferred to 5 ml 
plastic vials and incubated for 1 h at 37°C with 
1251-hGH (3 x lo5 cpm). Non-specific binding was 
determined in the presence of 1 ,ug unlabeled hGH. 
Reaction was terminated by transferring the cells 
to Eppendorf tubes, pelleting and counting, as 
described for homogenates. 
2.4. Modulation of receptor binding by hGH 
Synchronized cells (2 x 106/ml) were exposed to 
various concentrations of hGH at 37°C. Aliquots 
were removed every 30 min during the first 3 h of 
exposure, centrifuged (5 min, 500 x g) and the 
medium was decanted. The cell pellets were placed 
on ice and resuspended in an acid buffer (0.1% 
acetic acid, 150 mM NaCl, 0.1% BSA, pH 4) for 
3 min. This procedure was found to be optimal for 
the dissociation of cell surface-bound hormone 
without affecting cell viability (Ashkenazi, A. and 
Gertler, A., unpublished). After a 5-fold dilution 
in neutral buffer (25 mM Hepes, 150 mM NaCI, 
0.1% BSA, pH 7.4), the cells were pelleted and 
washed twice in the same buffer. Finally the cells 
were resuspended in HS-supplemented Fischer’s 
medium and the binding of 1251-hGH was assayed 
as described. 
2.5. Affinity labeling of lactogen receptors 
Affinity labeling was carried out either with cell 
homogenates or microsomal fractions, which were 
prepared from cell homogenates by centrifugation 
at 500 x g (20 min) followed by centrifugation of 
the supernatants at 100000 x g (1 h). Approx. 
0.5 mg homogenate proteins or 0.2 mg micro- 
somal proteins were incubated with 1251-hGH (1 or 
2 x lo6 cpm, respectively) in the absence or 
presence of excess unlabeled hGH (16 h, 25°C). 
Incubation was terminated by addition of 1 vol. 
ice-cold Hepes buffer (50 mM, pH 7.5) followed 
by centrifugation (5 min, 11000 x g). The pellets 
were washed 3 times to remove unbound “‘1-hGH 
and finally resuspended in 0.1 ml of the same buf- 
fer. DSS, freshly dissolved in dimethyl sulfoxide, 
was added to a final concentration of 0.5 mM. The 
crosslinking reaction was carried out for 15 min at 
0°C and stopped by the addition of 0.05 vol. Tris- 
HCI buffer (2 M, pH 7.5), followed by centrifuga- 
tion. Pellets were washed 3 times, resuspended in 
XAR-5 film). 
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sample buffer (60 mM Tris-HCl, pH 6.8,2% SDS, 
10% glycerol, 0.005% pyronin Y, 50 mM DTT), 
boiled (5 min), and subjected to SDS-PAGE 
(7.5%) as described by Laemmli [12], followed by 
autoradiography (Kodak intensifying screen and 
XAR-5 film). 
3. RESULTS AND DISCUSSION 
3.1. Displacement studies 
Human GH and oPRL were equally potent in 
competing for the binding of rz51-hGH to cell 
homogenates (fig.lA,C) with identical displace- 
ment curves in Nb2-11C and Nb2-SP cells. 
Scatchard analysis (fig.lB,D) yielded linear curves, 
indicating a single class of binding sites. The affini- 
ty for hGH and oPRL was identical in both cell 
lines (table 1). It should be noted that this affinity 
is lo-20-fold higher than those reported for nor- 
mal target tissues, such as mammary gland or liver 
[ 131. The & values are in good agreement with 
values reported for binding of hPRL to intact cells 
from the original Nb2 strain 131. Met14hGH, an an- 
HORMONE (n M) 
Fig.1. Displacement of the binding of “‘I-hGH to cell 
homogenates by oPRL or hGH. Competitive binding 
studies were carried out with Nb2-11C (A,B) or NbZSP 
(CD) cell homogenates, using ‘Z51-hCH as tracer and 
hGH (0) or oPRL (0) as displacers. Maximal specific 
binding (&) was 7077 f 880 cpm (A) and 10645 k 
1030 cpm (C). (B,D) Scatchard [14] analyses. 
Table 1 
Dissociation constants and receptor numbers in 
Nb2- 11 C and Nb,ZSP cell-homogenates 
Cell line Hormone Kda (PM) Receptors/cellb 
Nb2-1lC oPRL 127k 3 2927 f 208 
hGH 134 f 14 2867 + 271 
Nb2-SP oPRL 133 f 13 4156 + 180 
hGH 130 f 13 4577 + 382 
a Calculated from Scatchard plots described in fig.lB,D. 
Values are presented as means f SE of 3 experiments 
b As in a, assuming a hormone : receptor ratio of 1: 1 in 
binding 
tagonist of the mitogenic activity of lactogenic hor- 
mones in Nb2-11C cells [5], bound to the lactogen 
receptors of both cell lines with the same affinity, 
however, it was devoid of any effect on the 
lactogen-independent proliferation of Nb2-SP cells 
(not shown). The binding capacity in Nb2-SP cells 
was remarkably higher than in Nb2-11C cells (table 
1). This difference may result from down- 
regulation of lactogen receptors in Nb2-1lC cells 
due to the presence of lactogenic hormones in the 
FCS-supplemented culture medium, followed by 
an only partial recovery of receptors during syn- 
chronization of the cells in HS-supplemented 
medium. 
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Fig.2. Modulation of receptors by hGH. The binding of 
‘*‘I-hGH was assayed following exposure of NbZ-1lC 
(0) or NbZSP (A) cells to hGH at 10 ng/ml (A) or 
100 ng/ml (B). The specific binding at t = 0 was 3247 k 
75 cpm and 6597 k 152 cpm (Nb2-1lC and NbZSP 
cells, respectively). In all determinations from 60 to 
180 min, the specific binding in Nb2-SP cells was 
significantly (P < 0.05) lower than in Nb2-1lC cells. 
53 
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3.2. Modulation of receptor binding by hGH 
Exposure of Nb2 cells to hGH results in a rapid 
decrease in receptor binding, to -20% of the 
original levels, within 3 h (fig.2). Scatchard 
analysis (not shown) revealed that the decrease in 
binding results from down-regulation of receptors 
rather than from a change in affinity. Down- 
regulation was significantly more rapid in Nb2-SP 
cells, however, it should be noted that the initial 
receptor levels in these cells were higher. After ex- 
posure to hGH, the absolute amounts of “‘1-hGH 
bound/cell were similar in both cell lines. 
Therefore, the relatively more rapid down- 
regulation in Nb2-SP cells could result from their 
initially higher receptor levels. It is most likely that 
the down-regulation process was accompanied by 
receptor degradation, since the binding to cell 
1 2 3 4 
Fig-S. Affinity labeling of microsomal iactogen 
receptors. Microsomal fractions prepared in the 
presence of phenylmethyisulfonyl-fluoride (1 mM) and 
leupeptin (0.1 mM), from Nb2-11C (1,2) or NbZSP 
(3,4) cells were incubated with ‘251-hGH in the absence 
(1,3) or presence (2,4) of hGH. Crosslinking and SDS- 
Fig.4. Affinity labeling of lactogen receptors in Nb2-11C 
cell homogenates. Homogenates were incubated with 
‘251-hGH (1 x lo6 cpm) in the absence (1) or presence (2) 
of 1 pg oPRL. Crosslinking and SDS-PAGE were 
PAGE were carried out as described in the text. carried out as described in the text. 
homogenates decreased in a similar manner 
following exposure of the intact cells to hGH (not 
shown). 
3.3. Affinity labeling of lactogen receptors 
Lactogen receptors in Nb2-1lC and Nb2-SP 
microsomal fractions were covalently labeled with 
12%hGH (fig.3). Two major, specifically labeled 
species, corresponding to M, 97000 and 51000, 
were observed in both cell lines, indicating an M, 
of 75000 and 29000, respectively for the binding 
species. The intensity of the bands in NbZSP cells 
was higher, due to the higher receptor levels in 
these cells. Bands of similar M,, although less in- 
tense, were observed when SDS-PAGE was carried 
out under non-reducing conditions (not shown) in- 
dicating a lack of disulfide bonds that stabilize the 
quaternary structure. 
54 
Volume 210, number 1 FEBS LETTERS January 1987 
Affinity labeling of lactogen receptors in cell 
homogenates revealed one major specifically label- 
ed band (MT 82000) and two faint bands (Mr 68000 
and 56000) in Nb2-1lC cells (fig.4). The 82 kDa 
band was also observed in Nb2-SP cells, however, 
the other species appeared as a diffuse band of 
56-68 kDa (not shown). Excess oPRL prevented 
the labeling of these bands (fig.4, lane 2), whereas 
recombinant bovine GH had no effect (not 
shown), thus confirming the identity of the recep- 
tors as lactogenic rather than somatotropic binding 
sites in both cell lines. The differences in the it4, of 
the species labeled in homogenates and in 
microsomal fractions could be attributed to pro- 
teolytic activity present in the cell homogenates 
during incubation, originating in the cytosolic 
fractions. Indeed, when cell homogenates were 
prepared in the presence of 1 mM phenylmethyl- 
sulfonyl fluoride and 0.1 mM leupeptin (not 
shown), the 97 and 56 kDa bands were the major 
labeled species; however, they appeared in a dif- 
fuse manner. Values of 30-40 kDa have been 
observed for PRL-binding subunits in various 
tissues and species [13], and also in cow mammary 
gland (Ashkenazi, A., Madar, Z. and Gertler, A., 
submitted). Higher M, species (Mr 88000-91000) 
were observed in rat Leydig cells [ 151 and rat ovary 
[16,17]. In the former cases the size of the binding 
species was not affected by reducing agents, as 
reported here for Nb2 cells. However, in the latter 
cases [ 15,161, the high-Mr complex yielded the low- 
A4, complex under reducing conditions. Therefore, 
the quaternary structure of the PRL receptor and 
the nature of its inter-subunit interactions 
probably vary with the species and/or target tissue. 
3.4. Conclusion 
We have demonstrated that the lactogen recep- 
tors in lactogenic hormone-dependent and in 
autonomously proliferating Nb2 lymphoma cell 
lines do not seem to differ in their structural and 
binding properties. These findings suggest hat an 
aberration in a post-receptoral event of the 
mitogenic pathway, rather than in the receptor 
itself, is responsible for the spontaneous prolifera- 
tion of the NbZ-SP cell line. This is further 
substantiated in the finding that the hGH an- 
tagonist Met14hGH, which bound to the lactogen 
receptors of Nb2-SP cells, did not affect their 
lactogen-independent proliferation. However, 
there are a few other possibilities that cannot be 
precluded, namely that the lactogen r&eptors bt 
the two cell lines differ in: (i) their cytosolic signal- 
transducing domain, or (ii) their organization in 
the cell membrane, in features that do not affect 
the characteristics that were studied, or that 
Nb2-SP cells are sensitive to another unidentified 
mitogen present in the HS-supplemented medium, 
which signals them to proliferate through a dif- 
ferent receptor system. 
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